Výsledky vyhledávání - "Pamela Liliana Azcona"

Doxorubicin delivery by magnetic nanotheranostics enhances the cell death in chemoresistant colorectal cancer-derived cells

Autor: Pamela Liliana Azcona, Verónica Leticia Lassalle, María Julia Martín, Claudia Gentili

Publikováno v: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences. 158

Colorectal cancer (CRC) is a major cause of cancer death with a high probability of treatment failure. Doxorubicin (DOXO) is an efficient antitumor drug; however, most CRC cells show resistance to its effects. Magnetic nanoparticles (MNPs) are potent

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ea9c6fed7922a55e7e158b1cf100e243
https://pubmed.ncbi.nlm.nih.gov/33347979

Zobrazit plný text záznamu

Stimuli-responsive nanotheranostics intended for oncological diseases: In vitro evaluation of their target, diagnostic and drug release capabilities

Autor: Marcos Grunhut, Pamela Liliana Azcona, María Gabriela Montiel Schneider, Verónica Leticia Lassalle

Magnetic nanotheranostics were designed from iron oxide nanoparticles functionalized with folic acid (FA) and loaded with doxorubicin (Doxo) as a therapeutic agent. The incorporation of Doxo was carefully examined to attain a satisfactory drug loadin

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d7a77a0cd1288a8eac485f16569d5b53
https://pubs.rsc.org/en/content/articlelanding/2019/nj/c8nj05289a#!divAbstract

Zobrazit plný text záznamu

Folic acid magnetic nanotheranostics for delivering doxorubicin: toxicological and biocompatibility studies on Zebrafish embryo and larvae

Autor: Silvia del Valle Alonso, Carolina Martínez, Pamela Liliana Azcona, Maria Jimena Prieto, Verónica Leticia Lassalle, Daniela E. Igartúa

Publikováno v: CONICET Digital (CONICET)
Consejo Nacional de Investigaciones Científicas y Técnicas
instacron:CONICET

Doxorubicin (DOXO) is a chemotherapeutic agent widely used for the treatment of solid tumors and hematologic malignancies in both adults and children. However, DOXO causes short- and long-term cardiotoxicity and others undesirable side effects, such

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cab5c8277daeae6dc138173dce401f96
https://linkinghub.elsevier.com/retrieve/pii/S0041008X18304095

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání